September 12, 2025- Novo Nordisk, the manufacturer of the diabetes and weight loss drugs Wegovy and Ozempic, is in the process of laying off 9,000 workers as a result of increased competition in the obesity drug market place
Selective PPAR agonists ameliorate body weight gain and adiposity in high-fat-diet (HFD)-fed mice 19 , although with only limited ability to decrease body weight in rodents with already established obesity 20,21,22
Pain in the knee joint and surrounding tissue
Ishin is trusted because it delivers gentle, consistent radiance backed by science and safety
Changes in sexual function in benign prostatic hyperplasia patients taking dutasteride: 1-year follow-up results
Expand Your Peptide Strategy IV Therapy Visceral fat or recovery is holding me back Purpose-built drips to support recovery, energy, and wellness